Cognitive–behavioural therapy for psychosis

D. Kingdon

University of Southampton, Royal South Hants Hospital, Southampton SO14 0YG, UK. E-mail: dgk{at}soton.ac.uk

Like a magician pulling a rabbit from his hat, Turkington draws a positive result for cognitive therapy for schizophrenia from the literature – only for McKenna to put it back in again (Turkington/McKenna, 2003). Does it exist or not? McKenna’s arguments and table look convincing as, by excluding any study that does not have an active control, he reduces the number of studies he considers. But would he do the same for studies of antipsychotic medications? Or does he assume that patients, and raters evaluating patients, can detect no difference between taking, for example, placebo and haloperidol, or even haloperidol and olanzapine? In which case why are we giving them so much of the latter?

But even focusing only on the studies that he finds acceptable, he dismisses one (SoCRATES; Lewis et al, 2002) for having a positive effect over active control on auditory hallucinations (oh, for a drug that had such an effect over and above those currently available!) and another (Sensky et al, 2000) where a differential benefit of cognitive–behavioral therapy over befriending only became apparent 9 months after therapy ended. He completely omits other widely cited studies with active placebos and positive effects (e.g. Drury et al, 1996). He then does an unusual meta-analytic exercise in dismissing two small pilot studies by weighing them against each other and finding them to cancel out. Other meta-analyses (e.g. Pilling et al, 2002) using more conventional methodology have concluded differently and, fortunately, so has the National Institute for Clinical Excellence.

The rabbit exists and is multiplying rapidly (e.g. Durham et al, 2003).

EDITED BY STANLEY ZAMMIT

Declaration of interest

D.K. has published books and gives workshops on cognitive–behavioural therapy for schizophrenia.

REFERENCES

Drury, V., Birchwood, M., Cochrane, R., et al (1996) Cognitive therapy and recovery from acute psychosis: a controlled trial. II. Impact on recovery time. British Journal of Psychiatry, 169, 602 –607.[Abstract]

Durham, R.C., Guthrie, M., Morton, R. V., et al (2003) Tayside–Fife clinical trial of cognitive–behavioural therapy for medication-resistant psychotic symptoms: results to 3-month follow-up. British Journal of Psychiatry, 182, 303 –311.[Abstract/Free Full Text]

Lewis, S., Terrier, N., Haddock, G., et al (2002) Randomised controlled trial of cognitive–behavioural therapy in early schizophrenia: acute-phase outcomes. British Journal of Psychiatry, 181 (suppl. 43), s91 –s97.[Abstract/Free Full Text]

Pilling, S., Bebbington, P., Kuipers, E., et al (2002) Psychological treatments in schizophrenia: I. Meta-analysis of family intervention and cognitive behaviour therapy. Psychological Medicine, 32, 763 –782.[CrossRef][Medline]

Sensky, T., Turkington, D., Kingdon, D., et al (2000) A randomized controlled trial of cognitive–behavioural therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry, 57, 165 –172.[Abstract/Free Full Text]

Turkington, D./McKenna, P. J. (2003) Is cognitive–behavioural therapy a worthwhile treatment for psychosis? (debate). British Journal of Psychiatry, 182, 477 –479.[Free Full Text]


 

Author’s reply

P. J. McKenna

Fulbourn Hospital, Cambridge CB1 5EF. E-mail: peter.mckenna{at}virgin.net

Actually, the study of Durham et al (2003) which was carried out under blind conditions failed to find a significant advantage for cognitive therapy over active placebo. The authors state that ‘Repeated measures analyses of variance were first conducted with three levels of treatment (CBT v. SPT v. TAU) and three time points (baseline, post-treatment, follow-up). There were significant effects for time for all variables except the GAS but no significant time x treatment interaction effects or contrasts for any of the measures’. This was for ‘Changes in severity from baseline’, with an essentially similar finding for ‘Clinically significant improvement’.

REFERENCES

Durham, R. C., Guthrie, M., Morton, R. V., et al (2003) Tayside–Fife clinical trial of cognitive–behavioural therapy for medication-resistant psychotic symptoms. Results to 3-month follow-up. British Journal of Psychiatry, 182, 303 –311.[Abstract/Free Full Text]





This Article
Full Text (PDF)
Submit a response
Alert me when this article is cited
Alert me when eLetters are posted
Alert me if a correction is posted
Citation Map
Services
Email this article to a friend
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Google Scholar
Articles by Kingdon, D.
Articles by McKenna, P. J.
Articles citing this Article
PubMed
PubMed Citation
Articles by Kingdon, D.
Articles by McKenna, P. J.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals